Top Menu

Award Descriptions

Awards for Excellence Descriptions

The Nathan B. Eddy Memorial Award was established in memory of one of the pioneers in the field of drug dependence following his death in 1973. The award acknowledges outstanding research efforts that have advanced our knowledge of drug dependence. Nominees may be citizens of any country and are selected by the Awards committee. PLEASE INCLUDE THE FOLLOWING:
  1. Letter written by Nominator outlining the Nominee’s major accomplishments. Please use “nominee’s last name_accomplishments”, e.g. Jones_accomplishments in the attachment name.
  2. Current copy of Nominee’s curriculum vitae. Please use “nominee’s last name_CV”, e.g. Jones_CV in the attachment name.
  3. Two separate letters of support (additional nominators’ letters will not be considered). Please use “nominee’s last name_supportletter”, e.g. Jones_supportletter in the attachment name.
This award in memory of Marian W. Fischman, a respected leader in drug abuse research and an outstanding scientist, was established in 2001 to recognize the contributions of an outstanding woman scientist in drug abuse research. PLEASE INCLUDE THE FOLLOWING:
  1. Letter written by Nominator outlining the Nominee’s major accomplishments. Please use “nominee’s last name_accomplishments”, e.g. Jones_accomplishments in the attachment name.
  2. Current copy of Nominee’s curriculum vitae. Please use “nominee’s last name_CV”, e.g. Jones_CV in the attachment name.
  3. Two separate letters of support (additional nominators’ letters will not be considered). Please use “nominee’s last name_supportletter”, e.g. Jones_supportletter in the attachment name.
Incomplete applications will not be reviewed.
This award, established in 2000, is given annually to a member of CPDD who has been an exemplary mentor to developing researchers in the field of drug dependence. Individuals should be nominated by a former or current trainee. PLEASE INCLUDE THE FOLLOWING:
  1. Letter written by Nominator outlining the Nominee’s major accomplishments. Please use “nominee’s last name_accomplishments”, e.g. Jones_accomplishments in the attachment name.
  2. Current copy of Nominee’s curriculum vitae. Please use “nominee’s last name_CV”, e.g. Jones_CV in the attachment name.
  3. Two separate letters of support (additional nominators’ letters will not be considered). Please use “nominee’s last name_supportletter”, e.g. Jones_supportletter in the attachment name.
  4. List of current and past mentees.
Incomplete applications will not be reviewed.
This award, in memory of a respected leader in drug abuse research and a former Chairman and Executive Secretary of CPDD, was established in 1986 to recognize research contributions in any facet of the field of drug abuse. It is given annually to an investigator who has demonstrated excellence in their field of research, authored several publications, and not attained his/her 40th birthday by July 1st in the year of the award. PLEASE INCLUDE THE FOLLOWING:
  1. Letter written by Nominator outlining the Nominee’s major accomplishments. Please use “nominee’s last name_accomplishments”, e.g. Jones_accomplishments in the attachment name.
  2. Current copy of Nominee’s curriculum vitae. Please use “nominee’s last name_CV”, e.g. Jones_CV in the attachment name.
  3. Two separate letters of support (additional nominators’ letters will not be considered). Please use “nominee’s last name_supportletter”, e.g. Jones_supportletter in the attachment name.
Incomplete applications will not be reviewed.
The Distinguished Service Award was presented for the first time in 1994. The name was changed by CPDD in the recent past to the Martin and Toby Adler Distinguished Service Award. The Award was established to honor individuals who have made outstanding contributions to the field of drug abuse beyond scientific contributions, per se, which further the mission of CPDD. There will not be a call for nominations for the award. The Executive Committee of CPDD, which includes the President, President-Elect, Past-President, Treasurer, Public Policy Officer, and Executive Officer will nominate and review qualified candidates and make the final selection. The award includes a monetary gift, a plaque, and travel expenses to the annual scientific meeting.
This award is given to an individual who or to an organization that has made major contributions through the media that have enhanced the public understanding of scientific issues concerning drug use disorders. Nominations will be provided by Media Committee Members. 
As a memorial to this well-liked and respected administrator at NIDA, established in 1986, an award is given every other year for outstanding contributions in the area of scientific administration related to drugs of abuse. The recipient will receive a plaque, $1500 USD, and travel expenses, including up to 2 hotel room nights. PLEASE INCLUDE THE FOLLOWING:
  1. Letter written by Nominator outlining the Nominee’s major accomplishments. Please use “nominee’s last name_accomplishments”, e.g. Jones_accomplishments in the attachment name.
  2. A current copy of Nominee’s curriculum vitae. Please use “nominee’s last name_CV”, e.g. Jones_CV in the attachment name.
  3. Two separate letters of support (additional nominators’ letters will not be considered). Please use “nominee’s last name_supportletter”, e.g. Jones_supportletter in the attachment name.

Award will be granted in 2021

The Innovator Award, sponsored by Indivior, Inc., will recognize individuals who have developed innovative approaches in basic science, clinical research, or treatment and prevention science that reflect ground-breaking strides with potential for significant impact in the field of drug dependence. Such innovation can be in any research area, including methodological approaches or paradigms, drug or assay discoveries, drug delivery, laboratory procedures, analytic methods, conceptual advances, assessment/measurement, treatment approaches, prevention strategies or implementation. The Innovator Award is not meant to be recognition of lifetime achievement. Emphasis is placed on innovation, preferably relatively recent innovation, and potential impact. Candidates do not need to be CPDD members. PLEASE INCLUDE THE FOLLOWING:
  1. Name and email of nominee
  2. Letter describing their research that you feel supports their nomination
  3. CV of nominee